These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31604901)

  • 1. Daily Caffeine Consumption Is Associated with Decreased Incidence of Symptoms and Hemodynamic Changes During Pharmacologic Stress with Regadenoson.
    Posch MI; Kay MD; Harhash AA; Huang JJ; Krupinski EA; Abidov A; McMillan NA; Kuo PH
    J Nucl Med Technol; 2020 Mar; 48(1):73-76. PubMed ID: 31604901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hemodynamic and stress testing variables in patients undergoing regadenoson stress myocardial perfusion imaging to regadenoson with adjunctive low-level exercise myocardial perfusion imaging.
    Cabrera R; Husain Z; Palani G; Karthikeyan AS; Choudhry Z; Dhanalakota S; Peterson E; Ananthasubramaniam K
    J Nucl Cardiol; 2013 Jun; 20(3):336-43; quiz 344-5. PubMed ID: 23430361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminophylline and caffeine for reversal of adverse symptoms associated with regadenoson SPECT MPI.
    Doran JA; Sajjad W; Schneider MD; Gupta R; Mackin ML; Schwartz RG
    J Nucl Cardiol; 2017 Jun; 24(3):1062-1070. PubMed ID: 27025843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
    Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.
    Partington SL; Lanka V; Hainer J; Blankstein R; Skali H; Forman DE; Di Carli MF; Dorbala S
    J Nucl Cardiol; 2012 Oct; 19(5):970-8. PubMed ID: 22565239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.
    Tejani FH; Thompson RC; Iskandrian AE; McNutt BE; Franks B
    J Nucl Cardiol; 2011 Feb; 18(1):73-81. PubMed ID: 21082298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson.
    Bitar A; Mastouri R; Kreutz RP
    PLoS One; 2015; 10(6):e0130487. PubMed ID: 26098883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.
    Palani G; Ananthasubramaniam K
    Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Stress Perfusion MRI: Experience in Pediatric and Young-Adult Patients Following Arterial Switch Operation Utilizing Regadenoson.
    Noel CV; Krishnamurthy R; Masand P; Moffett B; Schlingmann T; Cheong BY; Krishnamurthy R
    Pediatr Cardiol; 2018 Aug; 39(6):1249-1257. PubMed ID: 29748700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of body mass index and type of low-level exercise on the side effect profile of regadenoson.
    Salgado-Garcia C; Jimenez-Heffernan A; Lopez-Martin J; Molina-Mora M; Aroui T; Sanchez de Mora E; Ramos-Font C; Rivera de Los Santos F; Ruiz-Frutos C
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1906-1914. PubMed ID: 28547175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common genetic polymorphisms of adenosine A2A receptor do not influence response to regadenoson.
    Berlacher M; Mastouri R; Philips S; Skaar TC; Kreutz RP
    Pharmacogenomics; 2017 Apr; 18(6):523-529. PubMed ID: 28358597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson.
    Noel CV; Krishnamurthy R; Moffett B; Krishnamurthy R
    Pediatr Radiol; 2017 Mar; 47(3):280-289. PubMed ID: 28035425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans.
    Lieu HD; Shryock JC; von Mering GO; Gordi T; Blackburn B; Olmsted AW; Belardinelli L; Kerensky RA
    J Nucl Cardiol; 2007 Jul; 14(4):514-20. PubMed ID: 17679059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPD1 polymorphism and response to regadenoson.
    Saab R; Zouk AN; Mastouri R; Skaar TC; Philips S; Kreutz RP
    Pharmacogenomics; 2015 Nov; 16(16):1807-15. PubMed ID: 26554440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect evidence of sympathetic stimulation by regadenoson.
    Farris GR; Hage FG; Kumar V; Iskandrian AE
    J Nucl Cardiol; 2019 Apr; 26(2):684-687. PubMed ID: 29948894
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping.
    van Dijk R; Kuijpers D; Kaandorp TAM; van Dijkman PRM; Vliegenthart R; van der Harst P; Oudkerk M
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1753-1759. PubMed ID: 28547666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age and gender as predictors of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: a substudy of the ASSUAGE trial.
    Rangel MO; Demori RM; Doukky R
    Am J Ther; 2013; 20(6):622-9. PubMed ID: 24100259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regadenoson, a novel pharmacologic stress agent for use in myocardial perfusion imaging, does not have a direct effect on the QT interval in conscious dogs.
    Zhao G; Serpllion S; Shryock J; Messina E; Xu X; Ochoa M; Belardinelli L; Hintze TH
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):467-73. PubMed ID: 19033827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial.
    Ballany W; Mansour K; Morales Demori R; Al-Amoodi M; Doukky R
    J Nucl Cardiol; 2014 Jun; 21(3):496-502. PubMed ID: 24519563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.